Teva Pharmaceutical Industries reported $207M in Net Income for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 766M 2787M
Aerie Pharmaceuticals AERI:US $ -41.96M 4.17M
ALKERMES ALKS:US $ 2.36M 24.78M
Amarin AMRN:US $ -1.63M 6.55M
Amgen AMGN:US $ 1646M 31M
Antares Pharma ATRS:US $ 3.79M 47.59M
AstraZeneca AZN:LN 550M 1011M
Biogen BIIB:US $ 448.5M 38.3M
Bristol Myers Squibb BMY:US $ 1055M 966M
Eli Lilly And LLY:US $ 1355.3M 761.5M
Endo International Ordinary Shares ENDP:US $ 41.52M 77.82M
Flexion Therapeutics FLXN:US $ -28556000 8.91M
Gilead Sciences GILD:US $ 1522M 207M
GlaxoSmithKline GSK:LN 1395M 322M
Henry Schein HSIC:US $ 166M 23.36M
Horizon Pharma HZNP:US $ -123.35M 313.91M
JAZZ PHA JAZZ:US $ 121.83M 11.58M
Lannett LCI:US $ -7.14M 164.81M
Merk MRK:US $ 1545M 1634M
Novartis NOVN:VX SF 2059M 35M
Patterson Companies PDCO:US $ 28.76M 20M
Perrigo Ordinary Shares PRGO:US $ 38.1M 213.1M
Pfizer PFE:US $ 5564M 686M
Phibro Animal Health PAHC:US $ 12.16M 0.64M
Revance Therapeutics RVNC:US $ -71.64M 6.67M
Sun Pharmaceuticals SUNP:IN IR 8941.5M 9583.3M
Supernus Pharmaceuticals SUPN:US $ 5.69M 25.07M
Takeda 4502:JP Y 200377M 3279M
Teva Pharmaceutical Industries TEVA:US $ 207M 129M
Xeris Pharmaceuticals Inc XERS:US -18411000 3.45M
Zoetis ZTS:US $ 559M 200M